Catalyst
Pit
Terminal
Pit Consensus
Insiders
Politicians
Institutions
News
Screener
More ▾
Terminal
Pit Consensus
Insiders
Politicians
Institutions
News
Screener
More ▾
☰
XENE
Xenon Pharmaceuticals Inc.
NASDAQ · Pharmaceutical Preparations
Last close
$37.19
· 2026-09-30
ABOUT
Exchange
NASDAQ
Sector
Healthcare
Industry
Pharmaceutical Preparations
Market cap
$3.60B
RECENT INSIDER TRADES
2026-10-01
· MORTIMER IAN
(PRESIDENT & CEO)
· BUY
2026-10-01
· Kelly Thomas Patrick
(Chief Financial Officer)
· BUY
2026-09-03
· Svoronos Dawn
(Director)
· OTHER
2026-08-31
· KENNEY CHRISTOPHER JOHN
(Chief Medical Officer)
· SELL
INSTITUTIONAL OWNERSHIP
Institutional holders
331
Shares held
109,213,701
Value
$6.15B
Percent of shares outstanding
112.78%
As of quarter end
2026-06-30
RECENT NEWS
Xenon Pharmaceuticals stock hits 52-week low at 36.06 USD
Xenon Pharmaceuticals grants 17,850 options and 10,500 RSUs to eight employees
XENE: Defence Therapeutics Appoints Finance Executive Sherry Aulin to Its Board of Directors
Xenon Pharmaceuticals Investigation Notice: SueWallSt Notifies Investors of Pending Investigation Into Xenon Pharmaceuticals (XENE)
Xenon Pharmaceuticals: Azetukalner Still Has Potential As An Epilepsy Candidate
Catalyst
Pit
Features
Coming soon
Pricing
Coming soon
Privacy
Terms
Disclaimer
Affiliate Terms
Contact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
Xenon Pharmaceuticals Inc. (XENE) · Stock Price, Insider Trades, Institutional Holdings · CatalystPit